Transferability of European-derived Alzheimer's disease polygenic risk scores across multiancestry populations.
Nicolas A, Sherva R, Grenier-Boley B et al.
Publication Details
Comprehensive information about this research publication
Authors
Abstract
Summary of the research findings
A polygenic score (PGS) for Alzheimer's disease (AD) was derived recently from data on genome-wide significant loci in European ancestry populations. We applied this PGS to populations in 17 European countries and observed a consistent association with the AD risk, age at onset and cerebrospinal fluid levels of AD biomarkers, independently of apolipoprotein E locus (APOE). This PGS was also associated with the AD risk in many other populations of diverse ancestries. A cross-ancestry polygenic risk score improved the association with the AD risk in most of the multiancestry populations tested when the APOE region was included. Finally, we found that the PGS/polygenic risk score captured AD-specific information because the association weakened as the diagnosis was broadened. In conclusion, a simple PGS captures the AD-specific genetic information that is common to populations of different ancestries, although studies of more diverse populations are still needed to better characterize the genetics of AD.
36,659 European ancestry cases, 63,137 European ancestry controls
Study Statistics
Key metrics and study information
Analysis
Comprehensive review of health and genetic findings
Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.
Analysis In Progress
Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.
Summary
Key Findings
Health Insights
Disease Analysis
Genetic Trait Analysis
Clinical Relevance
Scientific Assessment
Related Publications
Other publications that may be of interest
A genome-wide association study of mass spectrometry proteomics using a nanoparticle enrichment platform.
Suhre K
Nat Genet
HV102 protein level (protein group normalized intensity)
Inference of chronic obstructive pulmonary disease with deep learning on raw spirograms identifies new genetic loci and improves risk models.
Cosentino J
Nat Genet
Chronic obstructive pulmonary disease liability (machine learning-based score)
A genetic map of human metabolism across the allele frequency spectrum.
Zoodsma M
Nat Genet
Free cholesterol in small VLDL (PGS-adjusted)
Large-scale genome-wide analyses of stuttering.
Polikowsky HG
Nat Genet
Stuttering
Genome-wide association study and polygenic risk prediction of hypothyroidism.
Rand SA
Nat Genet
Thyroid stimulating hormone levels
Explore More Research
Discover the latest findings in health and genetic research